Pharmaceutical & Biotech US articles
- Incorporating Expanded Access Programs into your Drug Development Plan by Natalie Douglas, CEO Idis - Oct 2010
File size - 365KB - Pre-approval opportunities: An overview by Natalie Douglas, CEO Idis - Jun 2008
File size - 4.2MB - Boundaries of Expanded Access by Simon Estcourt - May 2008
File size - 88KB - Bio Process International - Regulatory Considerations in Named Patient Programs by Maria Kempshall - Feb 2008
File size - 140KB - Enhancing global market access strategies with named patient programs
File size - 1.0MB - Advance Access use of named patient programs to enable patient access and enhance global market development
File size - 296KB
